Qualigen Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Aixcrypto Holdings

15/11/2022 13:38

* Qualigen Therapeutics Inc  QLGN.OQ  reported a quarterly
adjusted loss of 10 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 13 cents per share.
    * Revenue rose 24.8% to $1.44 million from a year ago;
analysts
expected $1.62 million. 
    * Qualigen Therapeutics Inc's reported EPS for the quarter
was a
loss of 10 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Qualigen Therapeutics Inc shares had fallen by 17.6% this
quarter and lost 79.4% so far this year.
    * The company reported a quarterly loss of $4.06 million.
    * Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $4.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 01:37 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.13          -0.10          Beat
 Jun. 30 2022      -0.16          -0.11          Beat
 Mar. 31 2022      -0.17          -0.12          Beat
 Dec. 31 2021      -0.17          -0.20          Missed